Blood pressure management in patients with intracerebral and subarachnoid hemorrhage

Neurosurg Clin N Am. 2006 Sep:17 Suppl 1:25-40. doi: 10.1016/s1042-3680(06)80005-7.
No abstract available

Publication types

  • Review

MeSH terms

  • Antihypertensive Agents / adverse effects
  • Antihypertensive Agents / therapeutic use*
  • Blood Flow Velocity / drug effects
  • Blood Flow Velocity / physiology
  • Blood Pressure / drug effects*
  • Blood Volume / drug effects
  • Blood Volume / physiology
  • Brain / blood supply
  • Brain Ischemia / physiopathology
  • Brain Ischemia / prevention & control
  • Evidence-Based Medicine
  • Homeostasis / drug effects
  • Homeostasis / physiology
  • Humans
  • Intracranial Aneurysm / physiopathology
  • Intracranial Aneurysm / therapy
  • Intracranial Hemorrhage, Hypertensive / drug therapy*
  • Intracranial Hemorrhage, Hypertensive / physiopathology
  • Intracranial Pressure / drug effects
  • Intracranial Pressure / physiology
  • Labetalol / adverse effects
  • Labetalol / therapeutic use
  • Nicardipine / adverse effects
  • Nicardipine / therapeutic use
  • Oxygen Consumption / drug effects
  • Oxygen Consumption / physiology
  • Propanolamines / adverse effects
  • Propanolamines / therapeutic use
  • Subarachnoid Hemorrhage / drug therapy*
  • Subarachnoid Hemorrhage / physiopathology
  • Vasospasm, Intracranial / physiopathology
  • Vasospasm, Intracranial / prevention & control

Substances

  • Antihypertensive Agents
  • Propanolamines
  • Nicardipine
  • esmolol
  • Labetalol